BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 9206235)

  • 1. [An experimental study on corneal collagen shield vehicle for delivery of pilocarpine].
    Sun X; Chu R; Chen N
    Zhonghua Yan Ke Za Zhi; 1996 Mar; 32(2):143-6. PubMed ID: 9206235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An experimental study of gentamycin delivery into cornea and aqueous humor from the collagen corneal shield].
    Huang ZP; Wu JA
    Zhonghua Yan Ke Za Zhi; 1992 May; 28(3):170-2. PubMed ID: 1286608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The collagen shield. A new vehicle for delivery of cyclosporin A to the eye.
    Reidy JJ; Gebhardt BM; Kaufman HE
    Cornea; 1990 Jul; 9(3):196-9. PubMed ID: 2373013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of aqueous and vitreous concentration of moxifloxacin 0.5% after delivery via a dissolvable corneal collagen shield device.
    Hariprasad SM; Shah GK; Chi J; Prince RA
    J Cataract Refract Surg; 2005 Nov; 31(11):2142-6. PubMed ID: 16412929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An experimental study of a new route for Acyclovir administration for anti-keratitis therapeutic treatment.
    Wang B; Teng W; Han X
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Dec; 14(4):379-81. PubMed ID: 11471033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human intraocular penetration pharmacokinetics of moxifloxacin 0.5% via topical and collagen shield routes of administration.
    Hariprasad SM; Mieler WE; Shah GK; Blinder KJ; Apte RS; Holekamp NM; Thomas MA; Chi J; Prince RA
    Trans Am Ophthalmol Soc; 2004; 102():149-55; discussion 155-7. PubMed ID: 15747753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ocular pharmacokinetics of pilocarpine micron emulsion in rabbits].
    Xu Y; Chen Z; Song J; Zhang J; Xie L
    Zhonghua Yan Ke Za Zhi; 1999 Nov; 35(6):446-8. PubMed ID: 11835858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collagen shield delivery of tissue plasminogen activator: functional and pharmacokinetic studies of anterior segment delivery.
    Murray TG; Jaffe GJ; McKay BS; Han DP; Burke JM; Abrams GW
    Refract Corneal Surg; 1992; 8(1):44-8; discussion 48-53. PubMed ID: 1554639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ocular pharmacokinetics of 0.5% pilocarpine with sodium hyaluronate in rabbits].
    Xu Y; Song JZ; Pang GR; Chen ZJ; Zhang JJ; Lü XF
    Zhonghua Yan Ke Za Zhi; 2004 Feb; 40(2):87-9. PubMed ID: 15059558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aqueous humor pilocarpine and timolol levels after instillation of the single drug or in combination.
    Ellis PP; Wu PY; Riegel M
    Invest Ophthalmol Vis Sci; 1991 Mar; 32(3):520-2. PubMed ID: 2001926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penetration of cyclosporin A into the rabbit cornea and aqueous humor after topical drop and collagen shield administration.
    Kanpolat A; Batioglu F; Yilmaz M; Akbas F
    CLAO J; 1994 Apr; 20(2):119-22. PubMed ID: 8044977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Action of miosis of 1% pilocarpine liposome in rabbits].
    Zhang HC; Yao K
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Jun; 25(3):343-5. PubMed ID: 12905753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymeric pseudolatices bearing pilocarpine for controlled ocular delivery.
    Vyas SP; Ramchandraiah S; Jain CP; Jain SK
    J Microencapsul; 1992; 9(3):347-55. PubMed ID: 1403485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporine in collagen particles: corneal penetration and suppression of allograft rejection.
    Gebhardt BM; Varnell ED; Kaufman HE
    J Ocul Pharmacol Ther; 1995; 11(4):509-17. PubMed ID: 8574814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flux of topical pilocarpine to the human aqueous.
    Krohn DL
    Trans Am Ophthalmol Soc; 1978; 76():502-27. PubMed ID: 754381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of collagen cross-linking in collagen corneal shields on ocular drug delivery.
    Kuwano M; Horibe Y; Kawashima Y
    J Ocul Pharmacol Ther; 1997 Feb; 13(1):31-40. PubMed ID: 9029438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In situ gelling xyloglucan formulations for sustained release ocular delivery of pilocarpine hydrochloride.
    Miyazaki S; Suzuki S; Kawasaki N; Endo K; Takahashi A; Attwood D
    Int J Pharm; 2001 Oct; 229(1-2):29-36. PubMed ID: 11604255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pupillary response to four concentrations of pilocarpine in normal subjects: application to testing for Adie tonic pupil.
    Leavitt JA; Wayman LL; Hodge DO; Brubaker RF
    Am J Ophthalmol; 2002 Mar; 133(3):333-6. PubMed ID: 11860969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased partitioning of pilocarpine to the oily phase of submicron emulsion does not result in improved ocular bioavailability.
    Sznitowska M; Zurowska-Pryczkowska K; Dabrowska E; Janicki S
    Int J Pharm; 2000 Jul; 202(1-2):161-4. PubMed ID: 10915939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilocarpine-induced flare is physiological rather than pathological.
    Freddo TF; Neville N; Gong H
    Exp Eye Res; 2013 Feb; 107():37-43. PubMed ID: 23187102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.